Abstract
The feasibility and safety of transradial coronary intervention was demonstrated soon after the description of the transfemoral approach, despite which the use of the femoral artery still dominates in acute coronary syndrome intervention. The advantages of using the radial artery are virtual elimination of access site complications and an important reduction in bleeding, both of which are of utmost importance to the patient with myocardial infarction. Randomised controlled trials have now documented what seems inherent; that transradial intervention should bring with it an advantage in terms of morbidity and mortality in this cohort. The potential disadvantages in terms of speed of procedure and radiation exposure are negated by operator experience. Registries have illustrated that conversion on a large scale from the femoral to the transradial approach is safe and saves lives, most convincingly so in acute coronary syndrome intervention. This review discusses the potential benefits and risks of the alternative access sites in acute patients and explores how these are borne out in the published data.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
Campeau L. Percutaneous radial artery approach for coronary angiography. Catheter Cardiovasc Diagn. 1989;16(1):3–7.
Kiemeneij F, Laarman GJ. Transradial artery coronary angioplasty. Am Heart J. 1995;129:1–8.
Kiemeneji F, Laarman GL, et al. A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches: the access study. JACC. 1997;29(6):1269–75. A randomized comparison of 6-F procedures in 900 patients showing equivalent success but with no access site complications in the radial group.
Kwok C RS, Myint P, et al. Major bleeding after percutaneous coronary intervention and risk of subsequent mortality: a systematic review and meta-analysis. Open Heart 2014. A meta-analysis showing that any increase in major bleeding predicts an increase in both mortality and MACE.
Verheugt FW, Steinhubl SR, Hamon M, et al. Incidence, prognostic impact, and influence of antithrombotic therapy on access and nonaccess site bleeding in percutaneous coronary intervention. J Am Coll Cardiol Intv. 2011;4:191–7.
Amin AP, House JA, Safley DM, et al. Costs of transradial percutaneous coronary intervention. J Am Coll Cardiol Intv. 2013;6:827–34.
Rao SV, Patel MR. The value proposition in percutaneous coronary intervention. J Am Coll Cardiol Intv. 2013;6:835–7.
Kotowycz MA, Vladimír DV. Radial artery patency after transradial catheterization. Circ Cardiovasc Interv. 2012;5:127–33.
Saito S, Ikei H, et al. Influence of the ratio between radial artery inner diameter and sheath outer diameter on radial artery flow after transradial coronary intervention. Catheter Cardiovasc Interv. 1999;46:173–8.
Rathore S, Stables RH, et al. Impact of length and hydrophilic coating of the introducer sheath on radial artery spasm during transradial coronary intervention: a randomized study. JACC Cardiovasc Interv. 2010;3(5):475–83.
Pancholy S, Coppola J, et al. Prevention of radial artery occlusion-patent hemostasis evaluation trial (PROPHET study): a randomized comparison of traditional versus patency documented hemostasis after transradial catheterization. Catheter Cardiovasc Interv. 2008;72(3):335–40.
Mann T, Cubeddu G. Stenting in acute coronary syndromes: a comparison of radial versus femoral access sites. J Am Coll Cardiol. 1998;32(3):572–6.
Pristipino C, Trani C, et al. Major improvement of percutaneous cardiovascular procedure outcomes with radial artery catheterisation: results from the PREVAIL study. Heart. 2009;95(6):476–82.
Jolly SS, Amlani S, et al. Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials. Am Heart J. 2009;157(1):132–40.
Jolly SS, Yusuf S, et al. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet. 2011;377(9775):1409–20.
Jolly SS, Cairns J, Niemela K, et al. Effect of radial versus femoral access on radiation dose and the importance of procedural volume: a substudy of the multicenter randomized RIVAL trial. J Am Coll Cardiol Intv. 2013;6(3):258–66.
Valgimigli M, Gagnor A et al. Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomized multicenter trial. Lancet 2015.
Ratib K, Mamas MA, et al. Access site practice and procedural outcomes in relation to clinical presentation in 439,947 patients undergoing percutaneous coronary intervention in the UK. JACC Cardiovasc Interv. 2015;8(1):20–9.
Mustafa AH, Holdroyd E, et al. Transradial intervention in ST elevation myocardial infarction. Curr Cardiol Rep. 2015;17(5):30.
Romagnoli E, Biondi-Zoccai G, et al. Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study. J Am Coll Cardiol. 2012;60(24):2481–9.
Bernat I, Horak D. ST-segment elevation myocardial infarction treated by radial or femoral approach in a multicenter randomized clinical trial: the STEMI-RADIAL trial. J Am Coll Cardiol. 2014;63(10):964–72.
Mamas MA, Ratib K. Influence of access site selection on PCI-related adverse events in patients with STEMI: meta-analysis of randomised controlled trials. Heart. 2012;98(4):303–11.
Joyal D, Bertrand OF, et al. Meta-analysis of ten trials on the effectiveness of the radial versus the femoral approach in primary percutaneous coronary intervention. Am J Cardiol. 2012;109(6):813–8.
Karrowni W, Vyas A, et al. Radial versus femoral access for primary percutaneous interventions in ST-segment elevation myocardial infarction patients: a meta-analysis of randomized controlled trials. JACC Cardiovasc Interv. 2013;6(8):814–23.
Mamas MA, Ratib K, Routledge H, et al. Influence of arterial access site selection on outcomes in primary percutaneous coronary intervention: are the results of randomized trials achievable in clinical practice? J Am Coll Cardiol Intv. 2013;6:698–706.
Baklanov DV, Kaltenbach LA, et al. The prevalence and outcomes of transradial percutaneous coronary intervention for ST-segment elevation myocardial infarction analysis from the national cardiovascular data registry (2007 to 2011). J Am Coll Cardiol. 2013;61:420–6.
Mamas M, D’Souza S, et al. Use of the sheathless guide catheter during routine transradial percutaneous coronary intervention: a feasibility study. Catheter Cardiovasc Interv. 2010;75:596–602.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Helen Routledge and Sanjay Sastry declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Management of Acute Coronary Syndromes